On July 5, 2024, OncoCyte Corporation announced that it held its annual general meeting of shareholders on June 28, 2024, and declared voting results. Since there is no further information has been discussed between the company and Broadwood Capital, Inc. the campaign is considered to have been withdrawn.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.29 USD | -2.08% | +10.03% | +31.60% |
05/07 | OncoCyte Corporation Provides Information to the Shareholders | CI |
01/07 | OncoCyte Corporation(NasdaqCM:OCX) added to Russell 3000E Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.60% | 44.91M | |
-32.86% | 8.68B | |
+25.06% | 3.86B | |
+15.74% | 2.43B | |
-26.46% | 1.84B | |
-7.09% | 1.73B | |
+40.61% | 1.16B | |
+54.75% | 842M | |
-9.17% | 702M | |
-9.18% | 594M |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- OncoCyte Corporation Provides Information to the Shareholders